Back to trial details

Intake questionnaire

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Applying to Stanford University · Stanford, California

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Solid Tumor, Adult?
3. Are you able to travel to Stanford for study visits?